In 2004 Professor Andrew Lotery was one of a team of researchers who discovered the first gene to be linked to AMD. This was a world-leading medical breakthrough and was published in the New England Journal of Medicine, one of the most prestigious medical publications in the world. As a result of this breakthrough, Professor Lotery and his research team are collaborating with other research institutions in the hope that a cure, or improved treatment, will be found for AMD within the foreseeable future.
Please view Professor Lotery's University page to see details of research and papers published.
The aims of the vision research group are as follows:
To perform world class research to create better treatments and thus prevent blindness
To achieve this by attracting sufficient funding to allow the research to proceed quickly
To train the next generation of academic ophthalmologists and visual scientists
To disseminate our research findings in leading research journals
- To work as a team to achieve these goals
Professor Lotery and members of his team raise funds for research by undertaking personal challenges.
Stem cell and gene therapy research is included in the projects being undertaken by the vision science team.
Please view our newsletters for any recent news that may be of interest.
Results of Gene Therapy Trial